RZLT
Price:
$5.02
Market Cap:
$483.39M
Rezolute, Inc. is a clinical-stage biopharmaceutical company focused on developing groundbreaking therapies for metabolic conditions marked by persistent glucose imbalances, primarily serving the United States market. Its flagship product candidate, RZ358, a human monoclonal antibody, is currently progressing through Phase 2b clinical trials as a potential treatment for congenital hyperinsulinism, an exceptionally rare genetic disorder impacting pediatric patients. The company is also developing RZ402, a powerful and selective plasma kallikrein inhibitor, which is in Phase 1 clinical evaluation for the ongoing management of diabetic macular edema. Founded in 2010, the entity was formerly kno...[Read more]
Industry
Biotechnology
IPO Date
2013-01-14
Stock Exchange
NASDAQ
Ticker
RZLT
According to Rezolute, Inc.’s latest financial reports and current stock price. The company's current ROE is -58.82%. This represents a change of 298.71% compared to the average of -14.75% of the last 4 quarters.
The mean historical ROE of Rezolute, Inc. over the last ten years is -192.09%. The current -58.82% ROE has changed -69.38% with respect to the historical average. Over the past ten years (40 quarters), RZLT's ROE was at its highest in in the June 2018 quarter at 315.36%. The ROE was at its lowest in in the March 2018 quarter at -932.17%.
Average
-192.09%
Median
-68.33%
Minimum
-1736.13%
Maximum
753.94%
Discovering the peaks and valleys of Rezolute, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 62.28%
Maximum Annual ROE = 753.94%
Minimum Annual Increase = -417.09%
Minimum Annual ROE = -1736.13%
| Year | ROE | Change |
|---|---|---|
| 2025 | -45.90% | -18.88% |
| 2024 | -56.58% | 26.92% |
| 2023 | -44.58% | 62.28% |
| 2022 | -27.47% | -65.70% |
| 2021 | -80.09% | -70.99% |
| 2020 | -276.08% | -84.10% |
| 2019 | -1736.13% | -330.27% |
| 2018 | 753.94% | -417.09% |
| 2017 | -237.77% | 39.66% |
| 2016 | -170.25% | 35.66% |
The current ROE of Rezolute, Inc. (RZLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-49.02%
5-year avg
-50.92%
10-year avg
-192.09%
Rezolute, Inc.’s ROE is greater than Tyra Biosciences, Inc. (-42.66%), greater than Savara Inc. (-87.19%), greater than Geron Corporation (-28.90%), less than ProKidney Corp. (7.40%), greater than Kura Oncology, Inc. (-141.95%), greater than Maravai LifeSciences Holdings, Inc. (-44.72%), greater than Prime Medicine, Inc. (-188.82%), greater than Day One Biopharmaceuticals, Inc. (-23.43%), less than Nanobiotix S.A. (31.23%), greater than EyePoint Pharmaceuticals, Inc. (-110.54%),
| Company | ROE | Market cap |
|---|---|---|
| -42.66% | $1.68B | |
| -87.19% | $1.13B | |
| -28.90% | $808.32M | |
| 7.40% | $615.34M | |
| -141.95% | $881.53M | |
| -44.72% | $1.44B | |
| -188.82% | $583.39M | |
| -23.43% | $2.22B | |
| 31.23% | $1.84B | |
| -110.54% | $1.14B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rezolute, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rezolute, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Rezolute, Inc.'s ROE?
How is the ROE calculated for Rezolute, Inc. (RZLT)?
What is the highest ROE for Rezolute, Inc. (RZLT)?
What is the 3-year average ROE for Rezolute, Inc. (RZLT)?
What is the 5-year average ROE for Rezolute, Inc. (RZLT)?
How does the current ROE for Rezolute, Inc. (RZLT) compare to its historical average?